A head-to-head comparison between the VerifyNow®P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention-Reference-Cited by-同舟云学术

A head-to-head comparison between the VerifyNow®P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention

Published:2006-11 Issue:11 Volume:4 Page:2516-2518
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:

Author:

VAN WERKUM J. W.,VAN DER STELT C. A. K.,SEESING T. H.,HACKENG C. M.,TEN BERG J. M.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1538-7836.2006.02187.x/fullpdf

Reference6 articles.

1. Variability in platelet responsiveness to clopidogrel among 544 individuals;Serebruany;J Am Coll Cardiol,2005

2. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction;Matetzky;Circulation,2004

3. Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness;von Beckerath;Thromb Haemost,2006

4. Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug;Labarthe;J Am Coll Cardiol,2005

5. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study;Malinin;Thromb Res,2006

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjunctive Cilostazol in Patients With High Residual Platelet Reactivity After Drug-Eluting Stent Implantation: A Randomized, Open-Label, Single-Center, Prospective (ADJUST-HPR) Study;American Journal of Therapeutics;2023-04-25

2. Impact of Low-Dose Prasugrel on Platelet Reactivity in Chronic Phase of Post-Percutaneous Coronary Intervention (CHAPERON): a Prospective Cohort Study;Cardiovascular Drugs and Therapy;2023-04-25

3. A Sticky Situation: Variable Agreement Between Platelet Function Tests Used to Assess Anti-platelet Therapy Response;Frontiers in Cardiovascular Medicine;2022-07-01

4. Response to clopidogrel in patients undergoing lower extremity revascularization;Vascular;2022-05-19

5. Pharmacodynamics and Outcomes of a De-Escalation Strategy with Half-Dose Prasugrel or Ticagrelor in East Asians Patients with Acute Coronary Syndrome: Results from HOPE-TAILOR Trial;Journal of Clinical Medicine;2021-06-18